TipRanks
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market
GLENMARK
Glenmark Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see IN:GLENMARK full AI Analyst Report?

Glenmark Pharmaceuticals Limited (GLENMARK) Income Statement

5 Followers

Glenmark Pharmaceuticals Limited Income Statement

Last quarter (Q4 2026), Glenmark Pharmaceuticals Limited's total revenue was ₹37.71B, an increase of 17.99% from the same quarter last year. In Q4, Glenmark Pharmaceuticals Limited's net income was ₹3.01B. See Glenmark Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 169.83B₹ 133.63B₹ 126.45B₹ 116.56B₹ 123.05B
Gross Profit
₹ 80.84B₹ 88.38B₹ 80.66B₹ 72.45B₹ 77.57B
Operating Expenses
₹ 40.85B₹ 46.55B₹ 46.72B₹ 44.33B₹ 41.96B
Depreciation and Amortization
₹ 5.73B₹ 2.61B₹ 3.84B₹ 2.91B₹ 723.93M
EBITDA
₹ 27.67B₹ 21.68B₹ 18.30B₹ 14.29B₹ 19.12B
Operating Income
₹ 39.99B₹ 41.84B₹ 33.94B₹ 28.11B₹ 35.60B
Other Income/Expenses
₹ -20.14B₹ -27.85B₹ -33.58B₹ -25.72B₹ -21.19B
Pretax Income
₹ 19.85B₹ 13.99B₹ 364.95M₹ 2.40B₹ 14.41B
Net Income
₹ 13.62B₹ 10.47B₹ -15.02B₹ 2.97B₹ 9.42B
Per Share Metrics
Basic EPS
₹ 48.26₹ 37.11₹ -67.30₹ -6.01₹ 33.37
Diluted EPS
₹ 48.24₹ 37.11₹ -67.30₹ -6.01₹ 33.37
Weighted Average Shares Outstanding
 282.19M 282.19M 282.17M 282.17M 282.17M
Weighted Average Shares Outstanding (Diluted)
 282.31M 282.21M 282.18M 282.17M 282.17M
Currency in INR

Glenmark Pharmaceuticals Limited Earnings and Revenue History